Answers are grounded in this paper and cite their sources.
The diagnosis of PAP is based on CT and BAL cytology or lung histology, whereas the diagnosis of specific PAP-causing diseases requires GM-CSF antibody testing or genetic analysis. There are several therapies including WLL and augmentation therapy with GM-CSF available to treat PAP, but supporting evidence is still limited.
No takes yet. Share an insight, caveat, or question.
McCarthy et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: